Keith Goldan

Keith Goldan

Director of Finance/CFO at SYNDAX PHARMACEUTICALS, INC.

Net worth: 1 M $ as of 29/04/2024

52 year
Health Technology
Consumer Services
Retail Trade

Keith Goldan active positions

CompaniesPositionStartEnd
SYNDAX PHARMACEUTICALS, INC. Comptroller/Controller/Auditor 04/05/2023 -
Director of Finance/CFO 12/06/2022 -
Treasurer 12/06/2022 -

Career history of Keith Goldan

Former positions of Keith Goldan

CompaniesPositionStartEnd
OPTINOSE, INC. Director of Finance/CFO 31/12/2016 09/06/2022
FIBROCELL SCIENCE, INC. Director of Finance/CFO 17/03/2015 31/12/2016
Corporate Secretary 17/03/2015 16/06/2015
Treasurer 17/03/2015 31/12/2016
NUPATHE INC Director of Finance/CFO 03/05/2009 20/02/2014
Investor Relations Contact 21/03/2011 20/02/2014
Public Communications Contact 14/02/2011 20/02/2014
Director of Finance/CFO - 30/10/2008
REALM THERAPEUTICS PLC Director/Board Member 30/09/2004 12/10/2008
Director of Finance/CFO 30/09/2004 12/10/2008
Century Capital Associates Founder - -
Investment Committee Member - 20/06/2011
Corporate Officer/Principal - -
Director of Finance/CFO - -

Training of Keith Goldan

Robert H. Smith School of Business Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Statistics

International

United States 9
United Kingdom 3

Operational

Director of Finance/CFO 7
Treasurer 2
Director/Board Member 1

Sectoral

Health Technology 7
Consumer Services 3
Retail Trade 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies2
SYNDAX PHARMACEUTICALS, INC.

Health Technology

OPTINOSE, INC.

Health Technology

Private companies6

Health Technology

Health Technology

Health Technology

Health Technology

Retail Trade

Century Capital Associates

See company connections